Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

New atrial-selective antiarrhythmic agents covered by Nissan Chemical patent

Jan. 24, 2003

ALT-711 reduces left ventricular mass in DIAMOND trial

Jan. 23, 2003

HMR-1556 potently and selectively blocks the slowly activating delayed rectifier K+ current

Jan. 22, 2003

ANDROMEDA trial discontinued due to safety concerns

Jan. 22, 2003

Biprel launched in Canada for hypertension

Jan. 21, 2003

Ranexa terminates ventricular tachycardia in preclinical study

Jan. 21, 2003

Sex differences for NO-induced effects in sickle cell disease

Jan. 21, 2003

Clinical benefits induced by celecoxib in coronary artery disease

Jan. 20, 2003

Miravant presents novel porphyrins for the diagnosis and treatment of vascular disorders

Jan. 20, 2003

Miravant claims metalloporphyrin photosensitizers for cardiovascular PDT

Jan. 17, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld
Hematopoietic stem cell research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Korsana boosts Alzheimer’s work with reverse merger, $380M financing
BioWorld Science
Just over a month after emerging from stealth and disclosing a $150 million series A, Korsana Biosciences Inc. is making the leap to the public market via a...